Indegene Q1 FY27 Results Analysis: Revenue Surges 40%, PAT Flat on Elevated Costs (INDGN)
Indegene Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,063.10 Cr (+39.73% YoY) and PAT growth of -0.17% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,063.10 Cr (+39.73% YoY) |
| PAT (Q1) | Rs. 116.20 Cr (-0.17% YoY) |
| EBITDA margin | 16.39% (-402 bps YoY) |
| EPS (Q1) | Rs. 4.84 (-0.41% YoY) |
| Market cap | Rs. 12,399.75 Cr |
| CMP | Rs. 514.70 |
Quarter Snapshot
Indegene delivered strong revenue growth of 39.73% YoY, driven by acquisitions and organic momentum. EBITDA margin saw its first sequential improvement in a year, rising 211 bps QoQ to 16.39%, in line with management's guidance. However, PAT was flat due to elevated D&A and acquisition costs, and the margin remains 402 bps below last year. Management's trajectory towards a ~20% margin in H2 FY27 is on track, supported by declining D&A from Q2. The key risk remains the pending tax dispute of over Rs.167 Cr.
Key Investment Insights
Key Positives
- Revenue grew 39.73% YoY to Rs.1,063.1 Cr.
- EBITDA margin improved 211 bps QoQ to 16.39%, first sequential uptick.
- EBITDA grew 21.56% QoQ to Rs.174.2 Cr.
- Enterprise Commercial Solutions segment grew 43.96% YoY.
- Standalone revenue grew 33.29% YoY with EBITDA margin expansion of 331 bps YoY to 17.67%.
- TCPA exceptional provision unchanged at Rs.20.3 Cr, no additional provision in Q1.
Risk Factors
- PAT flat YoY (−0.17%) despite 39.73% revenue growth.
- EBITDA margin 402 bps below Q1 FY26 level of 20.41%.
- Other expenses surged 85.32% YoY due to acquisition cost base.
- D&A more than doubled YoY (+104.17%) suppressing PAT.
- Income tax dispute of Rs.43.69 Cr + Rs.123.41 Cr disclosed.
- Standalone revenue declined 7.47% QoQ, indicating sequential growth driven by subsidiaries.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.